Genetic Technologies to pilot GeneType in Breast Screen centers across U.S.

Genetic Technologies announces the company is establishing a clinical implementation study with breast imaging centers across New York, Miami and Houston. The initiative will pilot the integration of the geneType into breast imaging centers, assisting in the streamlining of care that is currently somewhat fragmented. It will be a significant step forward in personalised medicine, particularly in the context of breast density notification and supplemental screening options for those women at increased risk. This pioneering study stems from feedback from prominent employer and payor groups in the United States, that recognise women’s healthcare, particularly around breast cancer, contains the most promising health and economic benefits.